NDC Compounded Drug 83556-0101-1 Bevacizumab
Injection, Solution Intraocular
Compounded Drug Product Information
NDC Crossover Products Matching Bevacizumab
NDC crossover of Avastin 1.25mg/0.05ml with NDC 83556-0101 a human compounded drug with other similar products matching the same substance name (Bevacizumab) and the same administration route (intraocular) or dosage form (injection, solution).
| NDC | Proprietary Name | Non-Proprietary Name | Package Desc | Dosage Form | Route Name | Company Name |
|---|---|---|---|---|---|---|
| 69194-963-01 | 963 Bevacizumab 1.25mg/0.05ml Inj - Scls Mn | Bevacizumab | .05 mL in 1 SYRINGE | Injection, Solution | Parenteral | Pine Pharmaceuticals Llc |
| 69194-963-01 | 963 Bevacizumab 1.25mg/0.05ml Inj - Scls Mn | Bevacizumab | .05 mL in 1 SYRINGE | Injection, Solution | Parenteral | Pine Pharmaceuticals Llc |
| 71449-091-22 | Bevacizumab | Bevacizumab | 10 SYRINGE, PLASTIC in 1 CONTAINER > .08 mL in 1 SYRINGE, PLASTIC | Injection, Solution | Intraocular | Denver Solutions, Llc Dba Leiters Health |
| 71449-091-22 | Bevacizumab | Bevacizumab | 10 SYRINGE, PLASTIC in 1 CONTAINER > .08 mL in 1 SYRINGE, PLASTIC | Injection, Solution | Intraocular | Denver Solutions, Llc Dba Leiters Health |
| 71449-091-22 | Bevacizumab | Bevacizumab | 10 SYRINGE, PLASTIC in 1 CONTAINER > .08 mL in 1 SYRINGE, PLASTIC | Injection, Solution | Intraocular | Denver Solutions, Llc Dba Leiters Health |
| 71449-091-22 | Bevacizumab | Bevacizumab | 10 SYRINGE, PLASTIC in 1 CONTAINER > .08 mL in 1 SYRINGE, PLASTIC | Injection, Solution | Intraocular | Denver Solutions, Llc Dba Leiters Health |
| 71449-091-43 | Bevacizumab | Bevacizumab | .1 mL in 1 SYRINGE, PLASTIC | Injection, Solution | Intraocular | Denver Solutions, Llc Dba Leiters Health |
| 71449-091-43 | Bevacizumab | Bevacizumab | .1 mL in 1 SYRINGE, PLASTIC | Injection, Solution | Intraocular | Denver Solutions, Llc Dba Leiters Health |
| 71449-091-44 | Bevacizumab | Bevacizumab | 1 SYRINGE, PLASTIC in 1 CONTAINER > .13 mL in 1 SYRINGE, PLASTIC | Injection, Solution | Intraocular | Denver Solutions, Llc Dba Leiters Health |
| 71449-091-44 | Bevacizumab | Bevacizumab | 1 SYRINGE, PLASTIC in 1 CONTAINER > .13 mL in 1 SYRINGE, PLASTIC | Injection, Solution | Intraocular | Denver Solutions, Llc Dba Leiters Health |
| 71449-091-90 | Bevacizumab | Bevacizumab | 10 SYRINGE, PLASTIC in 1 CONTAINER > .11 mL in 1 SYRINGE, PLASTIC | Injection, Solution | Intraocular | Denver Solutions, Llc Dba Leiters Health |
| 71449-091-90 | Bevacizumab | Bevacizumab | 10 SYRINGE, PLASTIC in 1 CONTAINER > .11 mL in 1 SYRINGE, PLASTIC | Injection, Solution | Intraocular | Denver Solutions, Llc Dba Leiters Health |
| 71449-091-90 | Bevacizumab | Bevacizumab | 10 SYRINGE, PLASTIC in 1 CONTAINER > .11 mL in 1 SYRINGE, PLASTIC | Injection, Solution | Intraocular | Denver Solutions, Llc Dba Leiters Health |
| 71449-091-98 | Bevacizumab | Bevacizumab | 1 SYRINGE, PLASTIC in 1 CONTAINER > .08 mL in 1 SYRINGE, PLASTIC | Injection, Solution | Intraocular | Denver Solutions, Llc Dba Leiters Health |
| 71449-091-98 | Bevacizumab | Bevacizumab | 1 SYRINGE, PLASTIC in 1 CONTAINER > .08 mL in 1 SYRINGE, PLASTIC | Injection, Solution | Intraocular | Denver Solutions, Llc Dba Leiters Health |
| 71449-091-99 | Bevacizumab | Bevacizumab | 10 SYRINGE, PLASTIC in 1 CONTAINER > .09 mL in 1 SYRINGE, PLASTIC | Injection, Solution | Intraocular | Denver Solutions, Llc Dba Leiters Health |
| 81483-0041-5 | Avastin | Bevacizumab | 5 SYRINGE, GLASS in 1 TRAY > .05 mL in 1 SYRINGE, GLASS (81483-0041-1) | Injection, Solution | Intravitreal | Tailstorm Health Inc |
| 81483-0041-5 | Avastin | Bevacizumab | 5 SYRINGE, GLASS in 1 TRAY > .05 mL in 1 SYRINGE, GLASS | Injection, Solution | Intravitreal | Tailstorm Health Inc |
| 81483-0041-5 | Avastin | Bevacizumab | 5 SYRINGE, GLASS in 1 TRAY > .05 mL in 1 SYRINGE, GLASS | Injection, Solution | Intravitreal | Tailstorm Health Inc |
| 81483-0041-5 | Avastin | Bevacizumab | 5 SYRINGE, GLASS in 1 TRAY > .05 mL in 1 SYRINGE, GLASS | Injection, Solution | Intravitreal | Tailstorm Health Inc |
Frequently Asked Questions
What is the NDC number assigned to Avastin?
Avastin was assigned by its manufacturer with NDC product code 83556-0101. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for Avastin?
The NDC package code 83556-0101-1 was assigned to a .07 mL in 1 SYRINGE, PLASTIC of bevacizumab administered intraocular via injection, solution.
Who manufactures this product?
Avastin is manufactured by an outsourced facility and labeled by Turbare Manufacturing. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.
Which are the NDC crossover matchings for this product?
We found 20 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by Pine Pharmaceuticals LLC, Denver Solutions, LLC dba Leiters Health and Tailstorm Health INC with NDC product codes 69194-963-01, 69194-963-01, 71449-091-22, 71449-091-22, 71449-091-22, 71449-091-22, 71449-091-43, 71449-091-43, 71449-091-44, 71449-091-44, 71449-091-90, 71449-091-90, 71449-091-90, 71449-091-98, 71449-091-98, 71449-091-99, 81483-0041-5, 81483-0041-5, 81483-0041-5 and 81483-0041-5.